Clinical trials
Browse topics Search all clinical trials
The purpose of this study is to determine whether treatment of obstructive sleep apnea (OSA) with positive airway pressure starting shortly after acute ischemic stroke or high risk TIA (1) reduces recurrent stroke, acute coronary syndrome, and all-cause mortality 6 months after the event, and (2) improves stroke outcomes at 3 months in patients who experienced an ischemic stroke.
Multiple locations
Multiple locations
This is a single-cohort early feasibility trial to determine whether an investigational device called the Bidirectional Neural Bypass System can lead to the restoration of movement and sensation in the hand and wrist of up to three individuals with tetraplegia.
Feinstein Institute for Medical Research | 350 Community Dr | Manhasset | NY 11030
Feinstein Institute for Medical Research | 350 Community Dr | Manhasset | NY 11030
The goal of this research study is to understand the evolution of levodopa-induced dyskinesias (LID), a refractory and disabling side effect of the gold standard treatment of Parkinson's disease, in hopes of identifying information that can help slow or prevent the development of LID in future patients.
Feinstein Institute for Medical Research | 350 Community Dr | Manhasset | NY 11030
Feinstein Institute for Medical Research | 350 Community Dr | Manhasset | NY 11030
To determine the impacts of COVID-19 on inidivudals with spinal cord injury
Feinstein Institute for Medical Research | 350 Community Dr | Manhasset | NY 11030
Feinstein Institute for Medical Research | 350 Community Dr | Manhasset | NY 11030
The purpose of this study is to determine whether treatment of obstructive sleep apnea (OSA) with positive airway pressure starting shortly after acute ischemic stroke or high risk TIA (1) reduces recurrent stroke, acute coronary syndrome, and all-cause mortality 6 months after the event, and (2) improves stroke outcomes at 3 months in patients who experienced an ischemic stroke.
Staten Island University Hospital North Campus | 475 Seaview Ave | Staten Island | NY 10305
Staten Island University Hospital North Campus | 475 Seaview Ave | Staten Island | NY 10305
The goal of this research study is to provide essential baseline information concerning normal brain function that will serve as a comparison for patients with neurological diseases who are enrolled in independent research protocols...
Feinstein Institute for Medical Research | 350 Community Dr | Manhasset | NY 11030
Feinstein Institute for Medical Research | 350 Community Dr | Manhasset | NY 11030
ASPIRE is a randomized, double-blinded, phase 3 clinical trial designed to test the efficacy and safety of apixaban, compared with aspirin, in patients with a recent intracerebral hemorrhage (ICH) and high-risk non-valvular atrial fibrillation (AF)...
North Shore University Hospital | 300 Community Dr | Manhasset | NY 11030
North Shore University Hospital | 300 Community Dr | Manhasset | NY 11030
To determine whether continuation vs. discontinuation of statin drugs after spontaneous lobar intracerebral hemorrhage (ICH) is the best strategy; and whether the decision to continue/discontinue statins should be influenced by an individual's Apolipoprotein-E (APOE) genotype.
Staten Island University Hospital North Campus | 475 Seaview Ave | Staten Island | NY 10305
Staten Island University Hospital North Campus | 475 Seaview Ave | Staten Island | NY 10305
To evaluate the impact on cognitive decline of Semaglutide in patients with early Alzheimer's disease or MCI
Feinstein Institute for Medical Research | 350 Community Dr | Manhasset | NY 11030
Feinstein Institute for Medical Research | 350 Community Dr | Manhasset | NY 11030
A Phase 3, multicenter, randomized, double-blind, placebo-controlled study to assess the efficacy, safety, and tolerability of AVP-786 (deudextromethorphan hydrobromide [d6-DM]/quinidine sulfate [Q]) for the treatment of agitation in patients with dementia of the Alzheimer’s type
Zucker Hillside Hospital | 75-59 263rd Street | Glen Oaks | NY 11004
Zucker Hillside Hospital | 75-59 263rd Street | Glen Oaks | NY 11004